1. Home
  2. LFUS vs ARWR Comparison

LFUS vs ARWR Comparison

Compare LFUS & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Littelfuse Inc.

LFUS

Littelfuse Inc.

HOLD

Current Price

$404.86

Market Cap

10.3B

Sector

Energy

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$85.60

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFUS
ARWR
Founded
1927
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
10.2B
IPO Year
1996
2009

Fundamental Metrics

Financial Performance
Metric
LFUS
ARWR
Price
$404.86
$85.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$366.67
$83.40
AVG Volume (30 Days)
320.1K
2.4M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
0.77%
N/A
EPS Growth
N/A
99.80
EPS
2.96
N/A
Revenue
$757,853,000.00
$16,142,321.00
Revenue This Year
$14.65
N/A
Revenue Next Year
$6.98
N/A
P/E Ratio
$140.26
N/A
Revenue Growth
N/A
N/A
52 Week Low
$227.73
$15.01
52 Week High
$500.57
$95.49

Technical Indicators

Market Signals
Indicator
LFUS
ARWR
Relative Strength Index (RSI) 40.56 59.26
Support Level $385.67 $70.03
Resistance Level $426.31 $86.19
Average True Range (ATR) 14.57 4.14
MACD 0.47 0.84
Stochastic Oscillator 51.72 60.82

Price Performance

Historical Comparison
LFUS
ARWR

About LFUS Littelfuse Inc.

Littelfuse is a supplier of circuit protection products (such as fuses and relays) for the transportation, industrial, telecommunications, and consumer electronics end markets. Littelfuse also holds a minority power semiconductor business, primarily serving high-voltage industrial applications. Littelfuse sells globally across both distribution and direct channels, and organizes its business into the three segments of electronics, transportation, and industrial. Littelfuse is a serial acquirer of smaller, bolt-on adjacent firms.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Share on Social Networks: